We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.1B
AUM Growth
+$989M
(+9.8%)
Cap. Flow
+$432M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
14.96%
Holding
1,372
New
66
Increased
556
Reduced
543
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$45.7M |
| 2 |
Morgan Stanley
MS
|
+$44.1M |
| 3 |
Eli Lilly
LLY
|
+$32.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$30.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$29.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$51.6M |
| 2 |
Oracle
ORCL
|
+$40M |
| 3 |
Equity Residential
EQR
|
+$34.6M |
| 4 |
Citigroup
C
|
+$31.3M |
| 5 |
ExxonMobil
XOM
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.49% |
| 2 | Technology | 14.87% |
| 3 | Financials | 14.25% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Biogen
BIIB
$30.9B
| $26.2M | 0.24% |
95,997
-79,620
| -45% | -$22.5M |
|
102
Principal Financial Group
PFG
$24.5B
| $26.2M | 0.24% |
414,811
+111,281
| +37% | +$6.79M |
|
|
RTN
103
DELISTED
Raytheon Company
RTN
| $26.1M | 0.24% |
170,989
+29,497
| +21% | +$4.44M |
|
104
Thermo Fisher Scientific
TMO
$213B
| $25.8M | 0.23% |
168,253
-49,098
| -23% | -$7.5M |
|
105
AGNC Investment
AGNC
$12.8B
| $25.6M | 0.23% |
1,286,769
+306,000
| +31% | +$5.9M |
|
106
Altria Group
MO
$126B
| $25.5M | 0.23% |
356,808
-34,363
| -9% | -$2.49M |
|
107
Northrop Grumman
NOC
$77.5B
| $25.2M | 0.23% |
106,142
-17,157
| -14% | -$4.08M |
|
108
BioMarin Pharmaceuticals
BMRN
$11.9B
| $25M | 0.23% |
284,761
+109,033
| +62% | +$9.7M |
|
109
HCA Healthcare
HCA
$91.4B
| $24.9M | 0.23% |
280,273
+149,898
| +115% | +$12.5M |
|
110
Howmet Aerospace
HWM
$111B
| $24.9M | 0.22% |
1,232,817
+1,004,745
| +441% | +$19.7M |
|
111
Boston Properties
BXP
$11.8B
| $24.6M | 0.22% |
185,918
-113,345
| -38% | -$15M |
|
112
Willis Towers Watson
WTW
$29.9B
| $24M | 0.22% |
183,445
+169,973
| +1,262% | +$21.6M |
|
113
TJX Companies
TJX
$179B
| $23.9M | 0.22% |
605,452
+137,558
| +29% | +$5.3M |
|
114
Quanta Services
PWR
$84.8B
| $23.7M | 0.21% |
638,827
+38,180
| +6% | +$1.39M |
|
115
NetEase
NTES
$83.1B
| $23.5M | 0.21% |
413,955
-119,995
| -22% | -$6.46M |
|
116
Autodesk
ADSK
$52B
| $23.4M | 0.21% |
270,996
+250,552
| +1,226% | +$21M |
|
117
Intuit
INTU
$90.5B
| $23.3M | 0.21% |
200,983
-32,220
| -14% | -$3.86M |
|
118
F5
FFIV
$22.4B
| $23.1M | 0.21% |
162,177
-8,150
| -5% | -$1.16M |
|
119
Qualcomm
QCOM
$169B
| $22.9M | 0.21% |
398,575
+106,665
| +37% | +$6.19M |
|
120
Ford
F
$61.8B
| $22.8M | 0.21% |
1,959,653
+367,112
| +23% | +$4.56M |
|
|
DD
121
DELISTED
Du Pont De Nemours E I
DD
| $22.8M | 0.21% |
283,776
-48,092
| -14% | -$3.73M |
|
122
ConocoPhillips
COP
$144B
| $22.8M | 0.21% |
456,960
+7,279
| +2% | +$352K |
|
123
Verizon
VZ
$201B
| $22.6M | 0.2% |
463,548
-54,364
| -10% | -$2.73M |
|
124
PayPal
PYPL
$50.6B
| $22.6M | 0.2% |
524,802
-19,977
| -4% | -$836K |
|
125
American Tower
AMT
$80.9B
| $22.6M | 0.2% |
185,591
+9,110
| +5% | +$1M |
|
Similar funds
HF
KBC Group's Q1 2017 Portfolio in Review
As of Q1 2017, KBC Group held 1,372 positions worth $11.1B, up 9.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
KBC Group deployed $432M of net new capital in Q1 2017, opening 66 new positions and adding to 556 existing holdings. Its largest new stake was LogMein, Inc.: 156,863 shares worth $15.3M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $51.6M trimmed.
- KBC Group's largest Q1 2017 buy was LogMein, Inc.: 156,863 shares worth $15.3M.
- KBC Group added most to Microsoft in Q1 2017, an estimated $45.7M increase.
- KBC Group's biggest Q1 2017 reduction was Pfizer, cutting an estimated $51.6M.
- KBC Group fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $16.2M.
- KBC Group's ten largest holdings make up 15% of its $11.1B portfolio in Q1 2017.
- KBC Group opened 66 new positions and closed 69 in Q1 2017.
- KBC Group's portfolio value rose 9.8% quarter-over-quarter to $11.1B.
Based on KBC Group's 13F filing for Q1 2017, filed 10 May 2017.